Insider Selling: Colgate-Palmolive (NYSE:CL) CFO Sells 858 Shares of Stock

Colgate-Palmolive (NYSE:CL) CFO Henning I. Jakobsen sold 858 shares of the business’s stock in a transaction that occurred on Monday, September 9th. The stock was sold at an average price of $74.60, for a total transaction of $64,006.80. Following the completion of the sale, the chief financial officer now owns 39,031 shares of the company’s stock, valued at $2,911,712.60. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink.

NYSE:CL traded up $0.73 during midday trading on Wednesday, reaching $72.85. 2,235,866 shares of the stock traded hands, compared to its average volume of 3,492,830. The stock has a market capitalization of $62.80 billion, a P/E ratio of 24.53, a PEG ratio of 4.71 and a beta of 0.75. The company has a debt-to-equity ratio of 32.25, a quick ratio of 0.78 and a current ratio of 1.13. The company has a fifty day moving average of $72.68 and a 200 day moving average of $70.82. Colgate-Palmolive has a 12 month low of $57.41 and a 12 month high of $76.41.

Colgate-Palmolive (NYSE:CL) last announced its quarterly earnings results on Friday, July 26th. The company reported $0.72 earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of $0.72. Colgate-Palmolive had a net margin of 14.77% and a negative return on equity of 10,821.98%. The business had revenue of $3.87 billion for the quarter, compared to analyst estimates of $3.88 billion. During the same quarter last year, the firm earned $0.77 EPS. The company’s revenue was down .5% on a year-over-year basis. On average, analysts predict that Colgate-Palmolive will post 2.84 EPS for the current fiscal year.

The company also recently announced a quarterly dividend, which will be paid on Friday, November 15th. Stockholders of record on Wednesday, October 23rd will be issued a dividend of $0.43 per share. This represents a $1.72 dividend on an annualized basis and a dividend yield of 2.36%. Colgate-Palmolive’s dividend payout ratio is currently 57.91%.

Hedge funds and other institutional investors have recently bought and sold shares of the stock. Dimensional Fund Advisors LP lifted its position in Colgate-Palmolive by 3.4% during the fourth quarter. Dimensional Fund Advisors LP now owns 1,737,377 shares of the company’s stock valued at $103,412,000 after buying an additional 57,606 shares during the period. Geode Capital Management LLC increased its stake in shares of Colgate-Palmolive by 7.9% in the 4th quarter. Geode Capital Management LLC now owns 10,540,277 shares of the company’s stock worth $626,200,000 after acquiring an additional 768,550 shares in the last quarter. Stevens Capital Management LP purchased a new position in Colgate-Palmolive during the 1st quarter valued at about $11,885,000. Hurlow Wealth Management Group Inc. purchased a new position in Colgate-Palmolive during the 1st quarter valued at about $227,000. Finally, Hamilton Point Investment Advisors LLC lifted its position in Colgate-Palmolive by 1.1% during the 1st quarter. Hamilton Point Investment Advisors LLC now owns 40,015 shares of the company’s stock valued at $2,743,000 after acquiring an additional 432 shares during the period. 76.64% of the stock is currently owned by institutional investors.

Several research firms recently commented on CL. ValuEngine lowered shares of Colgate-Palmolive from a “buy” rating to a “hold” rating in a report on Thursday, August 1st. Bank of America set a $80.00 price target on shares of Colgate-Palmolive and gave the stock a “buy” rating in a research note on Friday, July 12th. Morgan Stanley upped their price target on shares of Colgate-Palmolive from $72.00 to $74.00 and gave the company an “equal weight” rating in a research report on Monday, July 29th. Citigroup raised their price objective on Colgate-Palmolive from $77.00 to $79.00 and gave the company a “neutral” rating in a research note on Tuesday, August 20th. Finally, Deutsche Bank raised their price objective on Colgate-Palmolive from $74.00 to $76.00 and gave the company a “hold” rating in a research note on Friday, July 12th. One analyst has rated the stock with a sell rating, twelve have assigned a hold rating and six have given a buy rating to the stock. The stock currently has a consensus rating of “Hold” and a consensus target price of $73.87.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. The company operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. It offers oral care products, including toothpastes, toothbrushes, and mouthwashes, as well as pharmaceutical products for dentists and other oral health professionals; and personal care products, such as liquid hand soaps, bar soaps, shower gels, deodorants and antiperspirants, skin care products, and shampoos and conditioners.

See Also: Leveraged Buyout (LBO)

Insider Buying and Selling by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.